Edges in Network
| Network | GSE5851_top500tf - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | EGR3 |
| Upstream (Parents) |
|---|
| (<<) MEOX2 → EGR3 |
| (<<) GATA4 → EGR3 |
| (<<) TWIST1 → EGR3 |
| (<<) TCF3 → EGR3 |
| (<<) PRRX1 → EGR3 |
| (<<) MAFF → EGR3 |
| (<<) NR1I2 → EGR3 |
| (<<) BATF3 → EGR3 |
| Downstream (Children) |
|---|
| EGR3 → ISL1 (>>) |
| EGR3 → HNF4A (>>) |
| EGR3 → BHLHE41 (>>) |
| EGR3 → HOPX (>>) |
| EGR3 → TFAP2B (>>) |
| EGR3 → LZTS1 (>>) |
| EGR3 → ETV1 (>>) |
| EGR3 → NR2F6 (>>) |
| EGR3 → SNAPC5 (>>) |
| EGR3 → KLF9 (>>) |
| EGR3 → FOSL1 (>>) |
| EGR3 → FOS (>>) |
| EGR3 → NKX6-1 (>>) |
| EGR3 → TCF25 (>>) |
| EGR3 → HSF1 (>>) |
| EGR3 → EGR2 (>>) |
| EGR3 → NR4A2 (>>) |
| EGR3 → HNF1A (>>) |
| EGR3 → MLLT10 (>>) |
| EGR3 → EGR1 (>>) |
| EGR3 → ZNF134 (>>) |
| EGR3 → BHLHE40 (>>) |
| EGR3 → HMBOX1 (>>) |
